The authors evaluated the five-year outcomes in low-risk patients undergoing isolated surgical aortic valve replacement (SAVR) or SAVR with concomitant procedures within the randomized PARTNER 3 trial. In the PARTNER 3 trial, 454 patients with severe, symptomatic, tricuspid aortic stenosis (AS) underwent surgery and were followed for five years.
ALERT!
This site is not optimized for Internet Explorer 8 (or older).
Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.
Tricuspid
January 23, 2025
In this article, the authors aimed to assess whether post-implant transcatheter aortic valve prosthesis multi-detector computed characteristics differ between patients with native tricuspid and bicuspid aortic valve stenosis, as well as the effect on valve performance and clinical outcomes.
January 9, 2025
This study examined the preoperative status and surgical outcomes of male versus female degenerative mitral valve regurgitation patients undergoing surgery. The authors reviewed the institutional database for all patients who underwent surgery for degenerative mitral regurgitation between 2013 and 2021.
November 21, 2024
This cohort study, called the Real-World Observational Study for Investigating the Prevalence and Therapeutic Options for Atrial Functional Mitral Regurgitation (REVEAL-AFMR), aimed to investigate the prevalence, clinical characteristics, and outcomes of mitral valve (MV) surgery in atrial functional mitral regurgitation (AFMR).
February 28, 2024
Recurrent tricuspid valve endocarditis is a difficult problem that is not uncommon. This video demonstrates how it can be solved with a CorMatrix graft.
November 28, 2023
In this CTSNet Innovation Video Competition winning video, the authors demonstrate how their experience with the use of the right atrial appendage for pulmonary valve position led them to design a technique to use the RAA valve for tricuspid valve replacement.
November 20, 2023
Recently, the Tricuspid Valve Academic Research Consortium (TVARC) released its first document, a consensus statement aimed at bridging the current knowledge gaps in the study of tricuspid regurgitation (TR).
November 1, 2023
Surgical tricuspid valve replacement (TVR) is associated with a high risk of postoperative atrioventricular (AV) block. However, placing pacemaker leads through a tricuspid bioprosthesis is discouraged since it might impair bioprosthesis function.
September 4, 2023
This is the clinical case of a totally endoscopic beating-heart second redo tricuspid valve replacement with a mechanical valve in a sixteen-year-old male patient.
March 31, 2023
Tricuspid valve (TV) treatment, at its current status, represents a real dilemma since different options are available but long-term results still to be seen and lots of new strategies are still to come.